Why Teva Pharmaceutical Shares Are Trading Lower By 11%? Here Are Other Stocks Moving In Friday's Mid-Day Session

Gainers

• SAI.TECH Global Corporation SAI jumped 269% to $5.61 after gaining around 25% on Thursday.
• CXApp Inc. CXAI shares jumped 138% to $16.80 after gaining more than 345% on Thursday.
• mCloud Technologies Corp. MCLD surged 74% to $0.5902. mCloud recently received a non-compliance notice from Nasdaq.
• Marpai, Inc. MRAI gained 68.1% to $2.74 after gaining 90% on Thursday.
• Peakstone Realty Trust PKST rose 65.5% to $19.29. Peakstone Realty Trust announced listing of common shares on the New York Stock Exchange.
• Inpixon INPX surged 60% to $1.16 after jumping around 128% on Thursday.
• FOXO Technologies Inc. FOXO gained 40.5% to $0.7001. FOXO Technology recently announced full year 2022 financial results and recent business highlights.
• Petros Pharmaceuticals, Inc. PTPI climbed 35.8% to $1.53.
• ICZOOM Group Inc. IZM gained 35% to $3.58. ICZOOM Group announced upgrade of its AI Customer Service System.
• China Natural Resources, Inc. CHNR gained 29.5% to $2.94. China Natural Resources will proceed with acquisition of Lithium Mine in Zimbabwe.
• Express, Inc. EXPR rose 24% to $0.8374 after the company announced it and WHP Global will acquire Bonobos for a combined $75 million.
• Bullfrog AI Holdings, Inc. BFRG gained 23% to $6.92.
• My Size, Inc. MYSZ jumped 22.3% to $1.8150. MySize posted FY22 revenue of $4.459 million.
• Beamr Imaging Ltd. BMR gained 21.6% to $1.80.
• BigBear.ai Holdings, Inc. BBAI rose 20% to $3.3498. BigBear.ai recently filed for a mixed shelf offering.
• LogicMark, Inc. LGMK gained 17.1% to $0.1850 after gaining around 8% on Thursday.
• SMX (Security Matters) Public Limited Company SMX shares climbed 16% to $2.62 after jumping 37% on Thursday.
• Remark Holdings, Inc. MARK jumped 15.4% to $1.42.
• Purple Innovation, Inc. PRPL gained 15% to $2.5750. Purple Innovation announced cooperative framework with Coliseum Capital.
• Abcam plc ABCM gained 14.1% to $15.41.
• Cipher Mining Inc. CIFR jumped 12.2% to $2.9750.
• Navidea Biopharmaceuticals, Inc. NAVB gained 11.6% to $0.2906. Navidea Biopharmaceuticals entered into $750,000 asset purchase agreement with Meilleur Technologies for rights to NAV4694.
• Mind Medicine (MindMed) Inc. MNMD shares gained 10.4% to $3.4216. Mind Medicine’s collaborators have released topline data from a double-blind, investigator-initiated trial evaluating lysergide major depressive disorder (MDD).
• NextDecade Corporation NEXT rose 10% to $5.70.
• QuidelOrtho Corporation QDEL gained 9.6% to $98.32. QuidelOrtho Corporation said it expects total revenues in Q1 FY23 to be $840 million-$850 million, compared to the consensus of $746.75 million, driven by the Labs business unit.
• JPMorgan Chase & Co. JPM rose 7.2% to $138.30 as the company reported Q1 net revenue (managed) of $39.3 billion, up 25% Y/Y, beating the consensus of $36.2 billion.

Losers

• Meta Materials Inc. MMAT fell 42% to $0.22 after the company announced pricing of a $25 million underwritten public offering.
• Pear Therapeutics, Inc. PEAR shares dropped 37.4% to $0.0741. Pear Therapeutics recently filed for Chapter 11 and said it will seek to sell its assets through a sales process.
• T Stamp Inc. IDAI fell 31.5% to $3.80 after the company announced pricing of a $5.2 million registered direct offering and concurrent private placement priced at-the-market.
• VCI Global Limited VCIG dropped 30% to $2.9599.
• Goldenbridge Acquisition Limited GBRG dropped 28% to $7.50.
• GlucoTrack, Inc. GCTK dipped 28% to $0.98. GlucoTrack announced a proposed underwritten offering of common stock.
• Catalent, Inc. CTLT dropped 25% to $47.51 after the company said its gene therapy manufacturing site in Harmans, MD experienced productivity issues and significantly reduced the expected revenue in fiscal Q3 associated with the site and will also impact Q4 sales.
• Uxin Limited UXIN dropped 24.4% to $1.18.
• Kalera Public Limited Company KAL fell 21% to $1.28 after dropping 14% on Thursday. Kalera recently received a notice of delisting form Nasdaq.
• Spirit AeroSystems Holdings, Inc. SPR dipped 20.3% to $28.33 following a report Boeing will likely halt some 737 deliveries amid an issue with a part made by Spirit.
• Alvotech ALVO fell 19.1% to $11.07 after the FDA issued a complete response letter for the company's AVT02 BLA.
• SAB Biotherapeutics, Inc. SABS fell 19% to $0.6150. SAB Therapeutics shares jumped around 98% on Thursday after the company said it has been granted Fast Track designation from the FDA for SAB-176 influenza immunotherapy with high cross-reactivity to multiple strains of influenza.
• Navidea Biopharmaceuticals NCMI fell 17.5% to $0.3526. The company recently filed a voluntary Chapter 11 petition in the U.S. Bankruptcy Court for the Southern District of Texas. The company announced a series of debt restructuring transactions likely to strengthen its balance sheet meaningfully and position it for long-term growth.
• ViewRay, Inc. VRAY fell 17.5% to $1.51. Stifel, BTIG and Oppenheimer downgraded the stock.
• Perma-Fix Environmental Services, Inc. PESI fell 17.5% to $8.06 after the company issued an update on recent contract awards.
• MediaAlpha, Inc. MAX fell 17.3% to $10.76.
• D-Wave Quantum Inc. QBTS fell 17% to $0.5401. D-Wave Quantum reported fourth-quarter revenues of $2.4 million, flat on a year-over-year basis.
• Carrols Restaurant Group, Inc. TAST dropped 16.6% to $2.92.
• EverQuote, Inc. EVER dipped 12.7% to $10.78.
• HeartCore Enterprises, Inc. HTCR fell 11.7% to $1.28 after dropping 15% on Thursday. HeartCore Enterprises recently announced it signed its tenth Go IPO contract.
• Teva Pharmaceutical Industries Limited TEVA dropped 11.4% to $8.21 after the company announced its partner Alvotech received a complete response letter from the FDA for the Biologics License Application for AVT02.
• Hingham Institution for Savings HIFS fell 11.3% to $207.00 after reporting a decline in Q1 EPS.
• Lucid Group, Inc. LCID dropped 8.7% to $7.55 after the company announced Q1 production and delivery totals.
• Nikola Corporation NKLA fell 8% to $0.8918.
• Panbela Therapeutics, Inc. PBLA fell 7% to $0.54. Panbela Therapeutics recently announced the first patient has been enrolled in the Phase II trial of CPP-1X-T.
• The Boeing Company BA shares declined 7% to $198.60 following a report suggesting the company warned of lower 737 Max production and deliveries because of a supplier issue.

Now Read This: Wall Street's Most Accurate Analysts Say Sell These 3 Tech Stocks Delivering High-Dividend Yields